首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2138篇
  免费   189篇
  国内免费   158篇
  2485篇
  2024年   6篇
  2023年   48篇
  2022年   73篇
  2021年   127篇
  2020年   105篇
  2019年   81篇
  2018年   73篇
  2017年   66篇
  2016年   49篇
  2015年   87篇
  2014年   98篇
  2013年   131篇
  2012年   59篇
  2011年   129篇
  2010年   65篇
  2009年   86篇
  2008年   86篇
  2007年   102篇
  2006年   93篇
  2005年   93篇
  2004年   71篇
  2003年   82篇
  2002年   46篇
  2001年   48篇
  2000年   39篇
  1999年   26篇
  1998年   39篇
  1997年   40篇
  1996年   29篇
  1995年   30篇
  1994年   23篇
  1993年   26篇
  1992年   30篇
  1991年   23篇
  1990年   20篇
  1989年   16篇
  1988年   24篇
  1987年   19篇
  1986年   24篇
  1985年   34篇
  1984年   27篇
  1983年   17篇
  1982年   18篇
  1981年   14篇
  1980年   10篇
  1979年   11篇
  1978年   7篇
  1977年   6篇
  1973年   9篇
  1971年   6篇
排序方式: 共有2485条查询结果,搜索用时 15 毫秒
101.
目的:探讨急性呼吸窘迫综合征(ARDS)合并慢性气道疾病患者的临床特征及影响预后的因素。方法:167例ARDS患者根据并发症发生情况分为对照组(单纯性ARDS组,A组,n=39)及观察组(ARDS合并慢性气道疾,B组,n=49,C组,n=41,D组,n=38),比较各组患者一般情况、临床特征、生化指标、治疗方式及预后状况,通过logistic回归分析ARDS合并慢性气道疾病患者预后的影响因素。结果:观察组(B、C、D组)年龄、中性粒细胞、IL-6、IL-8、TNF-α、白蛋白、pro-BNP、乳酸、氧合指数、住院时间、住院费用与对照组(A组)比较差异有统计学意义,P0.05;128例ARDS合并慢性气道疾病患者中死亡76例,好转52例,病死率59.38%;单因素分析结果显示,观察组(B、C、D组)患者中临床结局好转患者与死亡患者比较,白细胞、淋巴细胞、CRP、TNF-α、IL-8、降钙素、肌酐、pro-BNP、氧合指数、住院费用、机械通气时间、抗生素数量差异有统计学意义,P0.05;通过多因素logistic回归分析发现肌酐是影响ARDS合并慢性气道疾病的潜在危险因素,氧合指数为保护因素,P0.05。结论:ARDS合并慢性气道疾病的能量代谢紊乱程度可能较单纯ARDS加重,且两者炎性特征不同。肌酐、氧合指数是影响ARDS合并慢性气道疾病的重要影响因素。  相似文献   
102.
Tian  Suyan  Zhu  Xuetong  Sun  Xuejuan  Wang  Jinmei  Zhou  Qi  Wang  Chi  Chen  Li  Li  Shanji  Xu  Jiancheng 《中国病毒学》2020,35(6):811-819
Virologica Sinica - The temporal change patterns of laboratory data may provide insightful clues into the whole course of COVID-19. This study aimed to evaluate longitudinal change patterns of key...  相似文献   
103.
Obestatin is a gastrointestinal peptide having wide-ranging effects on cell proliferation; however, its mechanism of action remains poorly understood. Thus, the aim of the study was to elucidate the effect of exogenous obestatin on the postnatal structural development of the small intestine. Seven-day-old piglets with an average BW of 1.56 ± 0.23 kg were divided into four groups (n = 10) that received intragastrically obestatin (2, 10 or 15 μg/kg BW) or vehicle. After a 6-day experimental period, morphological analysis of gastrointestinal tract and small intestine wall (mitosis and apoptosis indexes, histomorphometry of mucosa and muscularis layers) was performed. The study revealed a seemingly incoherent pattern of the histological structure of the small intestine among the experimental groups, suggesting that the effect of obestatin is both intestinal segment specific and dose dependent. Histomorphometric analysis of the small intestine showed that higher doses of obestatin seem to promote the structural development of the duodenum while simultaneously hindering the maturation of more distal parts of the intestine. Intragastric administration of obestatin increased the crypt mitotic index in all segments of the small intestine with the strongest pro-mitotic activity following the administration of obestatin at a dose of 10 and 15 μg/kg BW. The significant differences in the number of apoptotic cells in the intestinal villi among the groups were observed only in proximal jejunum and ileum. In conclusion, it seems that obestatin shows a broad-spectrum of activity in the gastrointestinal tract of newborn piglets, being able to accelerate its structural development. However, the varied effect depending on the intestinal segment or the concentration of exogenous obestatin causes that further research is needed to clarify the exact mechanism of this phenomenon.  相似文献   
104.
The host‐microbe relationship is pivotal for oral health as well as for peri‐implant diseases. Peri‐implant mucosa and commensal biofilm play important roles in the maintenance of host‐microbe homeostasis, but little is known about how they interact. We have therefore investigated the early host‐microbe interaction between commensal multispecies biofilm (Streptococcus oralis, Actinomyces naeslundii, Veillonella dispar, Porphyromonas gingivalis) and organotypic peri‐implant mucosa using our three‐dimensional model. After 24 hr, biofilms induced weak inflammatory reaction in the peri‐implant mucosa by upregulation of five genes related to immune response and increased secretion of IL‐6 and CCL20. Biofilm volume was reduced which might be explained by secretion of β‐Defensins‐1, ‐2, and CCL20. The specific tissue reaction without intrinsic overreaction might contribute to intact mucosa. Thus, a relationship similar to homeostasis and oral health was established within the first 24 hr. In contrast, the mucosa was damaged and the bacterial distribution was altered after 48 hr. These were accompanied by an enhanced immune response with upregulation of additional inflammatory‐related genes and increased cytokine secretion. Thus, the homeostasis‐like relationship was disrupted. Such profound knowledge of the host‐microbe interaction at the peri‐implant site may provide the basis to improve strategies for prevention and therapy of peri‐implant diseases.  相似文献   
105.
C16 peptide and angiopoietin-1 (Ang-1) have been found to have anti-inflammatory activity in various inflammation-related diseases. However, their combined role in acute respiratory distress syndrome (ARDS) has not been investigated yet. The objective of this study was to investigate the effects of C16 peptide and Ang-1 in combination with lipopolysaccharide (LPS)-induced inflammatory insult in vitro and in vivo. Human pulmonary microvascular endothelial cells and human pulmonary alveolar epithelial cells were used as cell culture systems, and an ARDS rodent model was used for in vivo studies. Our results demonstrated that C16 and Ang-1 in combination significantly suppressed inflammatory cell transmigration by 33% in comparison with the vehicle alone, and decreased the lung tissue wet-to-dry lung weight ratio to a maximum of 1.53, compared to 3.55 in the vehicle group in ARDS rats. Moreover, C  +  A treatment reduced the histology injury score to 60% of the vehicle control, enhanced arterial oxygen saturation (SO2), decreased arterial carbon dioxide partial pressure (PCO2), and increased oxygen partial pressure (PO2) in ARDS rats, while also improving the survival rate from 47% (7/15) to 80% (12/15) and diminishing fibrosis, necrosis, and apoptosis in lung tissue. Furthermore, when C  +  A therapy was administered 4 h following LPS injection, the treatment showed significant alleviating effects on pulmonary inflammatory cell infiltration 24 h postinsult. In conclusion, our in vitro and in vivo studies show that C16 and Ang-1 exert protective effects against LPS-induced inflammatory insult. C16 and Ang-1 hold promise as a novel agent against LPS-induced ARDS. Further studies are needed to determine the potential for C16 and Ang-1 in combination in treating inflammatory lung diseases.  相似文献   
106.
以低温敏感型的"丰禾1号"和耐低温型的"郑单958"两个玉米品种为实验材料,采用GA3浸种的处理方式("丰禾1号"为20 mg·L-1、"郑单958"为5 mg·L-1),探究了GA3对低温胁迫条件下玉米种子萌发过程中种胚中可溶性糖和可溶性蛋白含量及淀粉酶活性和呼吸途径关键酶活性的影响。结果表明:低温胁迫条件下,GA3浸种处理显著提升了玉米种胚中可溶性糖含量及可溶性蛋白的积累,增强了低温胁迫下细胞的渗透势;α-淀粉酶、β-淀粉酶和总淀粉酶活性显著提高;提高了苹果酸脱氢酶(MDH)、丙酮酸激酶(PK)、联合酶(G-6-PDH和6-PGDH)的活性,提高了糖酵解(EMP)、三羧酸循环(TCA)、磷酸戊糖途径(PPP)途径的运转效率,保证了细胞的物质代谢和能量供应;GA3浸种处理可以显著提高种子对低温的抵抗能力,从而在低温胁迫条件下促进其萌发。  相似文献   
107.
目的研究儿童反复呼吸道感染与患儿肠道微生态平衡紊乱的关系。方法选择102例反复呼吸道感染患儿为研究组,167例急性肺炎患儿为肺炎对照组,142例健康体检儿童为正常对照组。采用16S rRNA荧光定量PCR检测3组对象肠道双歧杆菌及大肠埃希菌数量,计算B/E值,并比较3组研究对象细胞免疫功能。结果正常对照组、肺炎对照组以及研究组儿童肠道双歧杆菌数量依次降低,大肠埃希菌依次增多,B/E值依次降低,差异均有统计学意义(均P0.05)。正常对照组、肺炎对照组以及研究组儿童血液中CD3~+、CD4~+细胞水平以及CD4~+/CD8~+依次降低,CD8~+细胞水平依次增高,差异均有统计学意义(均P0.05)。结论儿童反复呼吸道感染与肠道微生态失衡具有一定相关性,肠道微生态稳态的维持可为反复呼吸道感染的防治提供新思路。  相似文献   
108.
呼吸系统疾病影响着全世界数百万人,主要病变发生在气管、支气管、肺部及胸腔,病变轻者多咳嗽、胸痛,重者呼吸困难、缺氧甚至呼吸衰竭,可造成多种并发症,导致患者严重残疾甚至死亡。治疗性抗体的临床使用为肺癌、哮喘以及各类呼吸道传染病等的治疗开辟了新途径。目前已有数十种抗体(antibodies,Abs)获得市场批准,而且还有更多的抗体药物正在临床开发中。这些Abs中的大多数是针对哮喘、肺癌、慢性阻塞性肺病、特发性肺纤维化以及呼吸道传染病等疾病。其中,呼吸道传染病的爆发具有传播迅猛、传染性强的特点,常引发全球关注,如当下肆虐全球的新型冠状病毒肺炎。针对呼吸道传染病的多种Abs为其临床治疗提供了新策略。基于此,综述了已获准和正在临床开发的适用于治疗呼吸道传染病的Abs,通过综述抗体治疗的分子机制、优势和发展趋势,以期为呼吸道传染病治疗中抗体药物的研发提供参考。  相似文献   
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号